Chemodex

(-)-Epicatechin

CHF 101.00
In stock
CDX-E0231-M0055 mgCHF 101.00
CDX-E0231-M02525 mgCHF 353.00
More Information
Product Details
Synonyms EC; epi-Catechin; NSC81161; (-)-cis-3,3',4',5,7-Pentahydroxyflavane, (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol
Product Type Chemical
Properties
Formula C15H14O6
MW 290.27
CAS 490-46-0
Source/Host Chemicals Isolated from plant source.
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in acetone:water (1:1, 10 mg/ml), DMSO (10 mg/ml), methanol or DMF (~12.5 mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key PFTAWBLQPZVEMU-UKRRQHHQSA-N
Smiles OC1=CC(O)=C(C[C@@H](O)[C@@H](C2=CC=C(O)C(O)=C2)O3)C3=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Epicatechin is a natural flavonoid found in green tea. It has been reported to possess an immense antioxidant effect which contributes to its therapeutic effect in diabetes and cancer conditions. The consumption of epicatechin has been shown to reduce blood glucose levels in diabetic patients, while its anticancer effect was attributed to its antioxidant properties, antiangiogenic and direct cytotoxicity to cancer cells. The activity of Epicatechin includes the ability to interact with and neutralize reactive oxygen species (ROS), and to modulate cell signaling including the MAP kinase pathway, which is involved in cell proliferation.

Product References

(1) F. Bonilla, et al.; Food Chem. 66, 209 (1999) | (2) M. Suganuma, et al.; Cancer Res. 59, 44 (1999) | (3) J. Terao; J. Med. Invest. 46, 159 (1999) (Review) | (4) J.Z. Xu, et al.; Br. J. Nutr. 91, 873 (2004) | (5) M.H. Ravindranath, et al.; Evidence-Based Compl. Altern. Med. 6, 523 (2009) | (6) C.G. Fraga & P.I. Oteiza; Free Radic. Biol. Med. 51, 813 (2011) (Review) | (7) J. Shay, et al.; Oxid. Med. Cell Longev. 2015, 181260 (2015) (Review) | (8) L.A. Abdulkhaleq, et al.; Vet. World 10, 869 (2017) (Review)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.